
Keywords: طبقه بندی بین المللی بیماری، اصلاح نهم، اصلاح بالینی; CAD; coronary artery disease; CHM; Chinese herbal medicine; CI; confidence interval; COPD; chronic obstructive pulmonary disease; EGFR-TKIs; epidermal growth factor receptor tyrosine kinase inhibitors; GMP; Good Manufacturing Practice; HR; hazard ratio; I